Blueprint Medicines Corp (NASDAQ:BPMC)

Delayed Data
As of Jan 14
 +1.98 / +2.61%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Blueprint Medicines Corp have a median target of 122.00, with a high estimate of 152.00 and a low estimate of 84.00. The median estimate represents a +56.67% increase from the last price of 77.87.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Blueprint Medicines Corp. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 62.32%
Growthannually -212.59%


Growthquarterly 322.98%
Growthannually -77.93%
Key to the earnings and sales forecast charts.